User:DPP4_Dagmar
Editor·2,533 edits·since 2025/04
DPP4_Dagmar is an editor on PeptidePedia Wiki, editing since 2025 / 4.
This editor works mainly on incretin biology and receptor pharmacology. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,533Total edits
24Logged here
18Articles touched
2025/04Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is incretin biology and receptor pharmacology.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Glucose-dependent insulinotropic polypeptide | 2 | 33 | 6% |
| Peptide supply chain | 1 | 39 | 3% |
| Fmoc chemistry | 1 | 39 | 3% |
| AmbioPharm | 1 | 37 | 3% |
| Satiety signalling | 1 | 28 | 4% |
| Beta cell function | 1 | 31 | 3% |
| Shenzhen Hybio Pharmaceutical | 1 | 37 | 3% |
| Arcuate nucleus | 1 | 31 | 3% |
| Receptor bias | 1 | 31 | 3% |
| Sigma-Aldrich (Shanghai) Trading | 1 | 35 | 3% |
| Custom peptide synthesis | 1 | 28 | 4% |
| Insulin secretion | 1 | 31 | 3% |
| Glucagon-like peptide-1 | 1 | 41 | 2% |
| Solid-phase peptide synthesis | 1 | 43 | 2% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.